Legend Biotech (LEGN) Return on Capital Employed: 2020-2025
Historic Return on Capital Employed for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to -0.19%.
- Legend Biotech's Return on Capital Employed rose 2.00% to -0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.19%, marking a year-over-year increase of 2.00%. This contributed to the annual value of -0.00% for FY2024, which is 17.00% up from last year.
- Legend Biotech's Return on Capital Employed amounted to -0.19% in Q3 2025, which was up 1.73% from -0.19% recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Return on Capital Employed peaked at -0.08% during Q4 2024, and registered a low of -1.23% during Q2 2021.
- In the last 3 years, Legend Biotech's Return on Capital Employed had a median value of -0.20% in 2024 and averaged -0.26%.
- In the last 5 years, Legend Biotech's Return on Capital Employed skyrocketed by 51,116bps in 2021 and then declined by 13bps in 2023.
- Quarterly analysis of 5 years shows Legend Biotech's Return on Capital Employed stood at -0.41% in 2021, then surged by 32bps to -0.40% in 2022, then dropped by 13bps to -0.33% in 2023, then climbed by 25bps to -0.08% in 2024, then increased by 2bps to -0.19% in 2025.
- Its Return on Capital Employed stands at -0.19% for Q3 2025, versus -0.19% for Q2 2025 and -0.11% for Q1 2025.